Genvor Partners with B2i Digital to Expand Investor Reach for AI-Driven Agricultural Solutions
November 26th, 2025 4:16 PM
By: Newsworthy Staff
Genvor Inc. has joined the B2i Digital platform to increase investor awareness of its AI-accelerated peptide technology that addresses $220 billion in annual global crop losses through sustainable agricultural solutions.

Genvor Inc. has partnered with B2i Digital, Inc. as a Featured Company to expand investor awareness of its AI-accelerated peptide platform and sustainable agricultural solutions. The collaboration will leverage B2i Digital's multi-channel digital marketing engine and targeted outreach campaigns to connect Genvor with investors interested in biological solutions for agriculture. David Shapiro, CEO of B2i Digital, expressed enthusiasm for Genvor's leadership and their clear articulation of the growing demand for sustainable agricultural technologies.
Genvor's proprietary BioCypher Algorithm represents a significant advancement in agricultural biotechnology, leveraging more than 50,000 designed peptides and over 30 years of foundational research. The platform has demonstrated impressive results, including 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species. This technology addresses the estimated $220 billion in annual global crop losses caused by plant pathogens, positioning Genvor at the forefront of sustainable crop protection innovation.
The timing of this partnership coincides with Genvor's accelerated momentum, including recently issued patents and active partnership discussions with major agricultural companies. Chad Pawlak, CEO of Genvor, emphasized that this represents a key moment to expand investor engagement, particularly for those who understand the value of the company's licensing-first business model. Genvor maintains a growing intellectual property portfolio, including two issued U.S. patents and one pending application covering 24 proprietary peptides.
In November 2025, Genvor achieved a significant milestone with the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor Inc. and the United States Department of Agriculture. This patent validation underscores the commercial potential of Genvor's seed-trait technologies for major row crops. The company's development pipeline spans multiple crops including corn, citrus, rice, soybeans, cotton, flax, and potato, with applications across both foliar spray solutions and seed traits.
Genvor's partnership with B2i Digital through https://b2idigital.com represents a strategic move to increase visibility among the investment community during a period of significant technological advancement and commercial opportunity. The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions, further validating the market potential of its AI-driven peptide platform. This investor awareness initiative comes at a crucial time as global agriculture faces increasing pressure to adopt more sustainable practices while maintaining crop yields and quality.
Source Statement
This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,
